Search results
Results from the WOW.Com Content Network
Trump's second term is bringing back some concerns from his first term, adding pressure to the health sector. Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year [Video]
"Every damn thing that they sell into the United States is going to have like a 25% (tariff) until they stop drugs from coming in. And let me tell you something, those drugs will stop so damn fast ...
Trump, who takes office on Jan. 20, 2025, said he would impose a 25% tariff on imports from Canada and Mexico until they clamped down on drugs, particularly fentanyl, and migrants crossing the ...
Generic, brand and reimbursement (drug tariff) price decay. Branded manufactures may build ongoing contracts with wholesalers so that the brand continues to be dispensed in pharmacies even though the prescriptions are generic. This means that an originator may offer an advantageous price to undercut the generic or parallel import. Wholesalers ...
The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by the University of California, San Francisco, Library and Center for Knowledge Management. DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents.
The Anti-Drug Abuse Act of 1988, which created the Office of National Drug Control Policy, was the product of bi-partisan support.It was co-sponsored in the House of Representatives by parties' leaders, Tom Foley and Robert Michel, [5] and it passed by margins of 346–11 and 87–3 in the House and Senate, respectively. [6]
Mexico is also facing a 25% tariff threat. LeBlanc said he and other officials had a "preliminary" conversation with Trump's incoming "border tsar" Tom Homan about the new plan. "I'm in encouraged ...
The drug policies put into place are enforced by the Food and Drug Administration and the Drug Enforcement Administration. Classification of Drugs are defined and enforced using the Controlled Substance Act, which lists different drugs into their respective substances based on its potential of abuse and potential for medical use. Four different ...